Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern.
A double avirulent mutant was isolated from the SADBern strain of rabies virus by two successive selection steps using neutralizing anti-glycoprotein monoclonal antibodies. Both mutations affect the triplet coding for amino acid 333 of the glycoprotein. The resulting virus, called SAG2, has a glutamate coded by GAA in position 333 instead of an arginine. This new codon differs by two nucleotides from all the arginine triplets. SAG2 is avirulent in adult mice by intracerebral and intramuscular routes and it protects mice against a challenge by the CVS strain. This double mutant is still avirulent after three successive passages in suckling mouse brain or after ten successive cycles of multiplication in cell culture. Because it is protective and genetically stable, SAG2 represents an improvement on SAG1 which is already used for oral vaccination of foxes in Switzerland and France. It could also be a candidate for oral vaccination of dogs against rabies.
Lafay
F
F
Laboratoire de Génétique des Virus, CNRS, Gif sur Yvette, France.
Bénéjean
J
J
Tuffereau
C
C
Flamand
A
A
Coulon
P
P
D000818:Animals; D000833:Animals, Suckling; D001921:Brain; D002460:Cell Line; D005260:Female; D007267:Injections; D007273:Injections, Intramuscular; D051379:Mice; D009154:Mutation; D016133:Polymerase Chain Reaction; D011819:Rabies Vaccines / Q000235:genetics* / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology
D011819:Rabies Vaccines; D014613:Vaccines, Attenuated